May 20, 2013
J.K. WallThe study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare
to pay for use of its brain imaging agent Amyvid.
More
May 16, 2013
Bloomberg NewsEli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major
developed countries.
More
May 14, 2013
Bloomberg NewsEli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta
is functioning as intended, the Indianapolis-based drugmaker said.
More
May 13, 2013
Associated PressDr. Jay Hess was picked to become the 10th dean in the school of medicine's 110-year history and the first dean in the past
five to come from outside IU.
More
May 13, 2013
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across
the country have been raising prices just because they can, according to a new study.
More
May 10, 2013
Bloomberg NewsThe drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual
sales by 2018.
More
May 8, 2013
IBJ StaffWarner relies on funds from the Indiana Family and Social Administration, but the FSSA recently decided to end that funding
after numerous complaints against the company went unresolved.
More
May 7, 2013
Mason KingFive of the six Hoosier firms that appear in the 2013 rankings slipped from their positions in last year's list of the largest
U.S. companies.
More
May 6, 2013
J.K. WallJohn Lechleiter has been suffering from a dilated aorta, Eli Lilly and Co. said Monday. Current CFO Derica Rice will take
his place until later this summer.
More
May 6, 2013
J.K. WallLilly will eliminate 1,624 positions from its U.S. sales force in July, according to a notice the company made to state officials.
But some of those workers may be rehired by the firm.
More
May 6, 2013
Associated PressMajor drugmakers, including Indianapolis-based Eli Lilly and Co., are closely watching Pfizer Inc.'s plan to sell Viagra directly
to consumers. The bold move blows up the drug industry's distribution model.
More
May 4, 2013
J.K. WallInfuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.
More
April 27, 2013
J.K. WallIndiana’s county-owned hospitals have rushed to acquire nursing homes in the past two years, opening a revenue stream
for both the hospitals and the long-term-care facilities. But the additional federal revenue that has driven these purchases
could come under threat.
More
April 27, 2013
Associated PressA decision to cut state funding by 38 percent for programs that help people stop smoking and try to prevent others from starting
worries those behind the state's tobacco cessation efforts.
More
April 25, 2013
Bloomberg NewsEli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay
availability of a potential treatment for Alzheimer’s disease.
More
April 24, 2013
IBJ Staff and Associated PressThe Indianapolis pharmaceutical company left its full-year profit forecast unchanged despite a spike in first-quarter earnings.
Revenue fell short of analyst expectations.
More
April 23, 2013
Associated PressA pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential
safety problems during an inspection.
More
April 22, 2013
J.K. WallInvestors are gaining confidence in the ability of major drugmakers, including Eli Lilly and Co., to improve their pipelines
of new products. The big pharma firms begin to report first-quarter earnings this week.
More
April 18, 2013
IBJ StaffThe pharmaceutical firm has $400 million in projects in the works for its facilities south of downtown. City officials have
advanced its request for tax breaks to a public hearing and final consideration May 1.
More
April 16, 2013
Associated PressThe possibility of thousands of Indiana residents becoming eligible for addiction treatment under the federal health overhaul
has state officials and providers preparing for an expansion.
More
April 15, 2013
Mason KingIndianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to
a new manufacturing plant and improvements to existing operations downtown.
More
April 15, 2013
J.K. WallInvestor smiles about new experimental cancer drugs and an aggressive play for the animal health market in China turned to
frowns after Lilly disclosed deep cuts to its U.S. sales force.
More
April 11, 2013
J.K. WallThe Indianapolis pharmaceuticals giant said Thursday that it would lay off hundreds of U.S. sales reps, as it prepares for
the loss of patent protection on two of its best-selling drugs.
More
April 11, 2013
Bloomberg NewsIndiana, Michigan and South Carolina saw the steepest declines in employer-backed coverage from 2000 to 2011, according to
a study released Thursday.
More
April 8, 2013
Associated PressLawyers for a security company being sued in the theft of $60 million worth of pharmaceuticals from an Eli Lilly and Co. warehouse
in Connecticut say there's no proof the thieves used a report it prepared about security weaknesses in the building.
More
"And the success of the Indiana GOP to not allow an expansion of Medicaid had nothing to do with Indiana hospitals' financial woes? Fixed that for you; editorial bias rebalanced. Seriously, there are so many things wrong with Obamacare that the only way one can view it as a success is to assume that it was designed to fail our way into a government single payor healthcare system. The system is complex, creates huge regulatory burdens and overhead and yet still does not have adequate means to control escalating health care costs. But then when you elect a 10th grade math drop out with no quantitative reasoning skills to be President of one of the world's most important economies in troubled times, you can't really be surprised by blatant stupidity.
No NIMBYs here to chase off a decent development. We don't need tons of parking and we'd happily play the role of host to a downtown Whole Foods.
Whatever you do, don't change a single thing about Broad Ripple. I want it to look just like it did in the late '70s, with 30% of the north side of Broad Ripple Avenue burned out and plenty of places to park. That's right Broad Ripple, NEVER CHANGE. Let the world pass you by, don't improve your empty, abandoned lots full of weeds. Someday someone will want to film a zombie movie here.
Hollywood could step in and make a movie about the history about this forlorn series. It could be a full celebrity cast of characters. WOW. http://www.advanceindiana.blogspot.com/2013/02/indiana-taxpayers-forced-to-pay-for.html
This shouldn't come as a shock to many. Austin is a great city, and Indy needs to take some notes. Austin invests in decent transit options, has a highly educated workforce, embraces a creative class, and --despite being the state capital-- is not micromanaged by rural and suburban legislators. Want Indy to grow? Invest in the city (i.e. spend money). Raise taxes a bit, and use the money to improve education. And keep the state legislature out of Indy the other 9 months of the year.